• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用聚环氧乙烷、白蛋白和肝素对聚合物生物材料进行表面改性以降低血栓形成倾向。

Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity.

作者信息

Amiji M, Park K

机构信息

Purdue University, School of Pharmacy, West Lafayette, IN 47907.

出版信息

J Biomater Sci Polym Ed. 1993;4(3):217-34. doi: 10.1163/156856293x00537.

DOI:10.1163/156856293x00537
PMID:8476792
Abstract

Appropriate surface modification has significantly improved the blood compatibility of polymeric biomaterials. This article reviews methods of surface modification with water-soluble polymers, such as polyethylene oxide (PEO), albumin, and heparin. PEO is a synthetic, neutral, water-soluble polymer, while albumin and heparin are a natural globular protein and an anionic polysaccharide, respectively. When grafted onto the surface, all three macromolecules share a common feature to reduce thrombogenicity of biomaterials. The reduced thrombogenicity is due to the unique hydrodynamic properties of the grafted macromolecules. In aqueous medium, surface-bound water-soluble polymers are expected to be highly flexible and extend into the bulk solution. Biomaterials grafted with either PEO, albumin, or heparin are able to resist plasma protein adsorption and platelet adhesion predominantly by a steric repulsion mechanism.

摘要

适当的表面改性显著提高了聚合物生物材料的血液相容性。本文综述了用水溶性聚合物进行表面改性的方法,如聚环氧乙烷(PEO)、白蛋白和肝素。PEO是一种合成的中性水溶性聚合物,而白蛋白和肝素分别是天然球状蛋白和阴离子多糖。当接枝到表面时,这三种大分子都具有降低生物材料血栓形成性的共同特征。血栓形成性降低是由于接枝大分子独特的流体动力学性质。在水性介质中,表面结合的水溶性聚合物预计具有高度柔韧性并延伸到本体溶液中。接枝有PEO、白蛋白或肝素的生物材料主要通过空间排斥机制能够抵抗血浆蛋白吸附和血小板粘附。

相似文献

1
Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity.用聚环氧乙烷、白蛋白和肝素对聚合物生物材料进行表面改性以降低血栓形成倾向。
J Biomater Sci Polym Ed. 1993;4(3):217-34. doi: 10.1163/156856293x00537.
2
Solution technique to incorporate polyethylene oxide and other water-soluble polymers into surfaces of polymeric biomaterials.
Biomaterials. 1991 Mar;12(2):144-53. doi: 10.1016/0142-9612(91)90193-e.
3
Surface modification with PEO-containing triblock copolymer for improved biocompatibility: in vitro and ex vivo studies.含聚环氧乙烷三嵌段共聚物的表面改性以改善生物相容性:体外和离体研究
J Biomater Sci Polym Ed. 1999;10(10):1089-105. doi: 10.1163/156856299x00702.
4
Surface modification of polymeric biomaterials: utilization of cyclodextrins for blood compatibility improvement.聚合物生物材料的表面改性:利用环糊精改善血液相容性。
J Biomed Mater Res A. 2007 Mar 1;80(3):539-53. doi: 10.1002/jbm.a.30925.
5
In vitro and in vivo studies of PEO-grafted blood-contacting cardiovascular prostheses.聚氧化乙烯接枝的血液接触心血管假体的体外和体内研究。
J Biomater Sci Polym Ed. 2000;11(11):1121-34. doi: 10.1163/156856200744228.
6
Enhanced blood compatibility of polymers grafted by sulfonated PEO via a negative cilia concept.通过负性纤毛概念磺化聚环氧乙烷接枝聚合物增强血液相容性。
Biomaterials. 2003 Jun;24(13):2213-23. doi: 10.1016/s0142-9612(03)00023-1.
7
Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials.基于壳聚糖的表面活性剂聚合物,旨在改善生物材料的血液相容性。
Colloids Surf B Biointerfaces. 2005 May 10;42(2):147-55. doi: 10.1016/j.colsurfb.2004.07.001.
8
The in vitro blood compatibility of poly(ethylene oxide)-grafted polyurethane/polystyrene interpenetrating polymer networks.聚(环氧乙烷)接枝聚氨酯/聚苯乙烯互穿聚合物网络的体外血液相容性
J Biomater Sci Polym Ed. 2000;11(2):197-216. doi: 10.1163/156856200743652.
9
Surface-Modifying Polymers for Blood-Contacting Polymeric Biomaterials.用于与血液接触的聚合生物材料的表面修饰聚合物。
Adv Exp Med Biol. 2020;1250:189-198. doi: 10.1007/978-981-15-3262-7_13.
10
Synthesis of a novel biomedical poly(ester urethane) based on aliphatic uniform-size diisocyanate and the blood compatibility of PEG-grafted surfaces.基于脂肪族均一尺寸二异氰酸酯的新型生物医学聚(酯-聚氨酯)的合成及聚乙二醇接枝表面的血液相容性
J Biomater Appl. 2018 May;32(10):1329-1342. doi: 10.1177/0885328218763912. Epub 2018 Mar 16.

引用本文的文献

1
Biomimetic polymers with phosphorylcholine groups as biomaterials for medical devices.带有磷酰胆碱基团的仿生聚合物作为医疗器械的生物材料。
Proc Jpn Acad Ser B Phys Biol Sci. 2024;100(10):579-606. doi: 10.2183/pjab.100.037.
2
Bio-Resorption Control of Magnesium Alloy AZ31 Coated with High and Low Molecular Weight Polyethylene Oxide (PEO) Hydrogels.涂覆有高分子量和低分子量聚环氧乙烷(PEO)水凝胶的镁合金AZ31的生物吸收控制
Gels. 2023 Sep 25;9(10):779. doi: 10.3390/gels9100779.
3
Strategies for surface coatings of implantable cardiac medical devices.
植入式心脏医疗设备的表面涂层策略。
Front Bioeng Biotechnol. 2023 May 9;11:1173260. doi: 10.3389/fbioe.2023.1173260. eCollection 2023.
4
Biomimic Zwitterionic Polyamide/Polyurethane Elastic Blending Fabrics.仿生两性离子聚酰胺/聚氨酯弹性混纺织物。
Biomimetics (Basel). 2023 May 10;8(2):198. doi: 10.3390/biomimetics8020198.
5
Zwitterionic Polypeptoids: A Promising Class of Antifouling Bioinspired Materials.两性离子聚肽:一类有前景的抗污仿生材料。
Materials (Basel). 2022 Jun 26;15(13):4498. doi: 10.3390/ma15134498.
6
Mass Spectrometry, Structural Analysis, and Anti-Inflammatory Properties of Photo-Cross-Linked Human Albumin Hydrogels.光交联人血清白蛋白水凝胶的质谱分析、结构分析和抗炎特性。
ACS Appl Bio Mater. 2022 Jun 20;5(6):2643-2663. doi: 10.1021/acsabm.2c00109. Epub 2022 May 11.
7
Control of Blood Coagulation by Hemocompatible Material Surfaces-A Review.血液相容性材料表面对血液凝固的控制——综述
Bioengineering (Basel). 2021 Dec 15;8(12):215. doi: 10.3390/bioengineering8120215.
8
Physically Switchable Antimicrobial Surfaces and Coatings: General Concept and Recent Achievements.物理可切换抗菌表面和涂层:一般概念与最新进展
Nanomaterials (Basel). 2021 Nov 16;11(11):3083. doi: 10.3390/nano11113083.
9
Analysis of N-acetyl cysteine modified polydimethylsiloxane shunt for improved treatment of hydrocephalus.分析 N-乙酰半胱氨酸修饰的聚二甲基硅氧烷分流器,以改善脑积水的治疗效果。
J Biomed Mater Res B Appl Biomater. 2021 Aug;109(8):1177-1187. doi: 10.1002/jbm.b.34780. Epub 2020 Dec 16.
10
Dialysis-Induced Cardiovascular and Multiorgan Morbidity.透析诱导的心血管及多器官疾病
Kidney Int Rep. 2020 Sep 9;5(11):1856-1869. doi: 10.1016/j.ekir.2020.08.031. eCollection 2020 Nov.